Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
How to create Content Workflow for Media Enterprises
A Content Management Workflow is used by Media Enterprises to have control over authorship, editing and publishing accesses and roles assignment for altering states, cycles and content types for…
|
How can a good Project Management ensure happy Drupal project delivery?
Drupal project management is not a topic or module covered, but it is through proper allocation of resources that Drupal developers can ensure to meet the goals
|
How will Artificial Intelligence power the future of Media and Publishing ?
The Digital Publishing industry is evolving & So is artificial intelligence. Adopting AI in the publishing sector with open doors never seen before.
|
How is the ecosystem of a Platform Strategy
Platform strategy is changing traditional businesses from linear pipelines to platforms. A platform enabled business model scales up a business creating connections
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
